זילוח כירורגי ובידוד הלבלב החזירי לבידוד האי

Executive Industry Relevance

Reliable procurement and preservation of porcine pancreata are critical for generating high-quality islets to support xenotransplantation research and scalable islet supply. Minimizing warm-ischemia and mechanical injury during organ isolation directly impacts islet viability, yield, and downstream translational potential. This protocol addresses a key bottleneck in the preclinical pipeline for diabetes cell therapy innovation and portfolio expansion.

Strategic Applications in Biopharma R&D

Early Discovery & Target Validation

• Enables robust interrogation of islet biology in a controlled, reproducible system.
• Supports functional validation of porcine islets for xenotransplantation feasibility studies.
• Facilitates mechanistic de-risking by preserving islet integrity for downstream assays.

Screening & Assay Development

• Provides standardized, high-viability islets for assay development and compound screening.
• Improves reproducibility and quantitative assessment of islet function and viability.
• Enables scalable preparation of biological material for repeated experimental workflows.

Translational & Preclinical Research

• Aligns with disease-relevant models for diabetes and cell therapy research.
• Ensures continuity from islet procurement through preclinical transplantation studies.
• Reduces biological variability, supporting risk-adjusted advancement decisions.

Pipeline & Workflow Integration

This surgical perfusion and isolation protocol positions porcine islet procurement at the interface of early discovery and preclinical model development for diabetes research.

• Discovery Biology: Supports hypothesis testing on islet viability and function under controlled procurement conditions.
• Screening: Delivers reproducible, high-quality islets for functional assays and compound evaluation.
• Analytics: Enables quantitative measurement of islet yield, purity, and viability for cross-condition comparison.
• Translational Research: Provides a foundation for preclinical xenotransplantation and encapsulation studies.
• Enterprise Reuse: Establishes a standardized protocol adaptable across research teams and model systems.

Operational & Enterprise Impact

• Scientific Value: Increases predictive confidence in islet-based translational models and target validation.
• Operational Value: Enhances standardization, reproducibility, and scalability of islet procurement workflows.
• Strategic Value: Improves go/no-go decision quality and reduces late-stage biological risk in cell therapy pipelines.
• Portfolio Impact: Enables risk-adjusted prioritization of diabetes and xenotransplantation programs.

Implementation Considerations

• Requires surgical expertise in vascular cannulation and organ dissection.
• Demands access to perfusion equipment, Ricordi chamber, and cell processing infrastructure.
• Necessitates cross-team standardization for reproducible islet isolation outcomes.
• Adaptable to different pig sizes with sheath selection and procedural adjustments.
• Warm-ischemia minimization is critical for optimal islet yield and viability.

Biopharma FAQs